For a better user experience please update your browser or use Chrome or Firefox browser.
Værktøjer
Publication detail
HomeCompetition enforcement in the pharmaceutical sector (2009-2017)
European competition authorities working together for affordable and innovative medicines
Der findes en nyere
udgave af denne publikation
Metadata for publikationen
Following the European Commission’s inquiry into the pharmaceutical sector in 2009, competition law enforcement and market monitoring in this area have been a high priority across the EU. This report provides an overview of how the Commission and the national competition authorities of the 28 Member States (‘European competition authorities’) have enforced EU antitrust and merger rules in the pharmaceutical sector in 2009-2017. It responds to concerns expressed by the Council and the European Parliament that anti-competitive practices of pharmaceutical companies may endanger patients access to affordable and innovative essential medicines.
- Offentliggjort:
- Emner: Konkurrencepolitik , Farmaceutisk og kosmetisk industri
- Emne: EU's konkurrencepolitik , konkurrenceret , lovgivning om apotekervæsen , markedsovervågning , medicinalindustri , medicinsk forskning , medicinudgifter , prisbestemmelser
|
PDF
|
|||
| ISSN | ISBN 978-92-79-98278-1 | DOI 10.2763/218954 | Katalognummer KD-07-18-081-EN-N |
- Released on EU publications website:
Dokumentvisning
Note:
Publikationen kan ikke vises i dokumentviseren. Åbn webversionen
Du kan få adgang til den på siden Download og sprog